A Phase I Study of VX-970 in Combination With Cisplatin and XRT in Patients With Locally Advanced HPV (-) Head and Neck Squamous Cell Carcinoma (HNSCC; SDC 10060121)
Phase of Trial: Phase I
Latest Information Update: 28 Sep 2017
At a glance
- Drugs M 6620 (Primary) ; Cisplatin
- Indications Head and neck cancer
- Focus Adverse reactions
- 07 Sep 2016 Planned primary completion date changed from 1 Nov 2017 to 1 Aug 2019.
- 07 Sep 2016 Status changed from not yet recruiting to recruiting.
- 07 Oct 2015 New trial record